Search Results

4 results found

CSL Launches ANDEMBRY® for the Prevention of Acute Attacks in Hereditary Angioedema (HAE) in Japan

About "ANDEMBRY® S.C. Injection 200mg Pens

https://newsroom.csl.com/2025-04-18-CSL-Launches-ANDEMBRY-R-for-the-Prevention-of-Acute-Attacks-in-Hereditary-Angioedema-HAE-in-Japan
METHODOLOGICAL NOTE on the EFPIA disclosure of transfers of value to healthcare professionals and organisations

ToVs solely related to over-the-counter medicines - ToVs excluded from the scope of the EFPIA Disclosure Code, such as informational and educational materials, items of medical utility, food and beverage, medical samples - Fees charged by logistics agencies assisting in organising travel and meetings

https://www.csl.com/-/media/shared/documents/vifor-disclosures/tov/2023_methodologicalnote_switzerland_20240626.pdf
CSL Vifor Methodological Note - Ireland 2024

TOVs solely related to over-the-counter medicines

https://www.csl.com/-/media/shared/documents/vifor-disclosures/methodological-notes/cslviforireland_method_2023_.pdf
Microsoft Word - 20230627_MethodologicalNote_Switzerland_2022

ToVs solely related to over-the-counter medicines - ToVs excluded from the scope of the EFPIA Disclosure Code, such as informational and educational materials, items of medical utility, food and beverage, medical samples - Fees charged by logistics agencies assisting in organising travel and meetings

https://www.csl.com/-/media/shared/documents/vifor-disclosures/methodological-notes/methodological-note_2022_ch.pdf